Skip to main content
. 2020 Jul 30;268(1):125–132. doi: 10.1007/s00415-020-10117-w

Table 1.

Criteria for eligibility, per arm of the systematic review

Epidemiological studies Intervention studies
Inclusion criteria Inclusion criteria
 Includes human participants diagnosed with idiopathic PD;  Includes human participants diagnosed with idiopathic PD and FOG;
 Includes both male and female participants;  Includes ≥ 10 participants with FOG in the final analysis;
 Includes ≥ 100 participants with FOG in the final analysis;  Reports sex distribution of study participants;
 Reports prevalence of FOG within the cohort;  Published between June 2014 – December 2019;
 Reports sex distribution within the cohort and within FOG subgroup;  Published in English or Dutch
 Observational cohort studies (retrospective or prospective) and cross-sectional studies;
 Ambulatory, outpatient or community-based settings only;
 Published in English or Dutch
Exclusion criteria Exclusion criteria
 Studies that enroll participants who are receiving a particular intervention;  Inpatient or acute care settings;
 Inpatient or other acute care settings;  Interventions specifically targeted to either men, or women (e.g. hormonal therapy in women);
 Other studies that cannot be expected to provide generalizable estimates of prevalence  Interventions specifically targeted to a specific subgroup of PD patients with FOG (e.g. DBS populations)

PD Parkinson’s disease, FOG freezing of gait, DBS deep brain stimulation